Occult Cancer of the Fallopian Tube in BRCA-1 Germline Mutation Carriers at Prophylactic Oophorectomy: A Case for Recommending Hysterectomy at Surgical Prophylaxis
- 1 February 2001
- journal article
- case report
- Published by Elsevier in Gynecologic Oncology
- Vol. 80 (2), 176-180
- https://doi.org/10.1006/gyno.2000.6071
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Germline BRCA2 Mutation in a Patient with Fallopian Tube Carcinoma: A Case ReportGynecologic Oncology, 2000
- Evidence of a founder BRCA1 mutation in ScotlandBritish Journal of Cancer, 2000
- Molecular Evidence Linking Primary Cancer of the Fallopian Tube to BRCA1 Germline MutationsGynecologic Oncology, 2000
- Cancer Risks in BRCA2 Mutation CarriersJNCI Journal of the National Cancer Institute, 1999
- BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum*1Obstetrics & Gynecology, 1998
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.Journal of Clinical Oncology, 1996
- Linkage analysis of 26 Canadian breast and breast-ovarian cancer familiesHuman Genetics, 1995
- Risks of cancer in BRCA1-mutation carriersThe Lancet, 1994